Search Results

Here you will find the range of pharmaceutical products that we offer in the UK for immunodeficiency, haemophilia, and other rare and serious diseases.

https://www.cslbehring.co.uk/products/product-range

CSL Behring is a specialty biotherapeutics company that is committed to treating people with rare and serious medical conditions.

https://www.cslbehring.co.uk/products

CSL Behring is a global leader in the plasma protein biotherapies industry. We research, develop, manufacture and market biotherapies, which are used to treat serious and rare conditions.

https://www.cslbehring.co.uk/our-company

Product Name Beriplex P/N 250 IU powder and solvent for solution for injection Active Ingredient factor IX, factor II, factor VII, factor X, protein C, protein S Composition Beriplex is presented as powder and solvent for solution for injection containing human prothrombin complex Legal Category POM:

https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/april-2025-update/product-info---beriplex-0425.pdf

Product Name Idelvion 250 IU powder and solvent for solution for injection Active Ingredient Albutrepenonacog alfa (recombinant coagulation factor IX, albumin fusion protein) Composition One vial contains nominally 250 IU of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP), (INN = albutrepenonacog alfa).

https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/april-2025-update/product-info-idelvion-0425.pdf

Product Name Idelvion 250 IU powder and solvent for solution for injection Active Ingredient Albutrepenonacog alfa (recombinant coagulation factor IX, albumin fusion protein) Composition One vial contains nominally 250 IU of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP), (INN = albutrepenonacog alfa).

https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/march-2025-update/product-info-idelvion-vat-3.pdf

CSL Behring is committed to improving the quality of life for people with rare and serious diseases worldwide.

https://www.cslbehring.co.uk/terms-of-use

Product Name Riastap 1 g Powder for solution for injection / infusion

https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/april-2025-update/product-info---riastap-0425.pdf

Product Name Respreeza Active Ingredient human alpha1-proteinase inhibitor Composition 1,000 mg powder and solvent for solution for infusion.

https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/april-2025-update/product-info---respreeza-0425.pdf

Product Name Hizentra 200 mg/ml solution for subcutaneous injection Active Ingredient Human normal immunoglobulin Composition One ml contains:

https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/march-2025-update/product-info---hizentra-inc-pfs-update-march-2025.pdf